Evidence map›Paper›PMID 27641306›Full record

ArticleCell stem cell2016

DNA Damage-Induced HSPC Malfunction Depends on ROS Accumulation Downstream of IFN-1 Signaling and Bid Mobilization.

Alpaslan Tasdogan, Suresh Kumar, Gabriele Allies, Julia Bausinger, Franziska Beckel, Helmut Hofemeister, Medhanie Mulaw, Vikas Madan, Karin Scharffetter-Kochanek, Michaela Feuring-Buske and 4 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Cell stem cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. [Interferon-α mediating the functional damage of CD56Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2023
    Article
  11. Article
  12. Metabolic regulation of somatic stem cells in vivo.Nature reviews. Molecular cell biology · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Inflammation and hematopoietic stem cells aging.Blood science (Baltimore, Md.) · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Alpaslan TasdoganInstitute of Immunology, University Hospital, 89081 Ulm, Germany; Department of Dermatology, University Hospital, 89081 Ulm, Germany.
Suresh KumarInstitute of Immunology, University Hospital, 89081 Ulm, Germany.
Gabriele AlliesInstitute of Immunology, University Hospital, 89081 Ulm, Germany.
Julia BausingerInstitute of Human Genetics, University Hospital, 89081 Ulm, Germany.
Franziska BeckelInstitute of Immunology, University Hospital, 89081 Ulm, Germany.
Helmut HofemeisterGenomics, BioInnovations Zentrum, Technische Universität, 01307 Dresden, Germany.
Medhanie MulawInstitute of Experimental Cancer Research, University Clinics, 89081 Ulm, Germany.
Vikas MadanInstitute of Immunology, University Hospital, 89081 Ulm, Germany.
Karin Scharffetter-KochanekDepartment of Dermatology, University Hospital, 89081 Ulm, Germany.
Michaela Feuring-BuskeDepartment of Internal Medicine III, University Hospital, 89081 Ulm, Germany.
Konstanze DoehnerDepartment of Internal Medicine III, University Hospital, 89081 Ulm, Germany.
Günter SpeitInstitute of Human Genetics, University Hospital, 89081 Ulm, Germany.
A Francis StewartGenomics, BioInnovations Zentrum, Technische Universität, 01307 Dresden, Germany.
Hans Joerg FehlingInstitute of Immunology, University Hospital, 89081 Ulm, Germany. Electronic address: joerg.fehling@uni-ulm.de.
University Hospital Ulm · DETU Dresden · DEInstitute of Clinical Cancer Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mouse mutants with an impaired DNA damage response frequently exhibit a set of remarkably similar defects in the HSPC compartment that are of largely unknown molecular basis. Using Mixed-Lineage-Leukemia-5 (Mll5)-deficient mice as prototypical examples, we have identified a mechanistic pathway linking DNA damage and HSPC malfunction. We show that Mll5 deficiency results in accumulation of DNA damage and reactive oxygen species (ROS) in HSPCs. Reduction of ROS efficiently reverses hematopoietic defects, establishing ROS as a major cause of impaired HSPC function. The Ink4a/Arf locus also contributes to HSPC phenotypes, at least in part via promotion of ROS. Strikingly, toxic ROS levels in Mll5

Indexed as

DNA DamageSignal TransductionAcetylcysteineAdministration, OralAnimalsAnimals, NewbornBH3 Interacting Domain Death Agonist ProteinCyclin-Dependent Kinase Inhibitor p16Genetic LociHematopoiesisHematopoietic Stem CellsHistone-Lysine N-MethyltransferaseInterferon Type IIntracellular SpaceMicePoly I-CAcetylcysteineBH3 Interacting Domain Death Agonist ProteinCyclin-Dependent Kinase Inhibitor p16Histone-Lysine N-MethyltransferaseInterferon Type IMLL5 protein, mousePoly I-CReactive Oxygen SpeciesReceptors, Interferon

Identifiers

PMID27641306
OpenAlexW2520955529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.